Status: Recruiting
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.
Participants needed: 80
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Lund UniversityUpdated: Sep 25, 2024Locations: 1
Eligibility criteria
Age 18-70 years [+2]
Pregnancy or breast-feeding [+12]